logo
This Giant Bird Went Extinct 600 Years Ago. Scientists Say They Can Resurrect It.

This Giant Bird Went Extinct 600 Years Ago. Scientists Say They Can Resurrect It.

Yahoo11-07-2025
Here's what you'll learn when you read this story:
Only a few months after announcing the controversial 'de-extinction' of the dire wolf, Colossal Biosciences has now set its sights on restoring the nine species of giant moa that roamed New Zealand some 600 years ago.
The biotech company plans on extracting DNA from moa bones and comparing to them to living relatives—such as the emu and the tinamou—to see what edits need to be made to bring back these flightless legends.
Although this project will include more DNA edits than the dire wolf project, many scientists are skeptical that any resulting genetically modified organism will be anything more than a facsimile of the original, leaving them unable to fulfill the moa's original ecological role and relegating them to a life of captivity.
Earlier this year, scientists at the Texas-based Colossal Biosciences boldly announced the 'world's first de-extinction' by bringing back the long dead dire wolf.
Nicknamed Romulus, Remus, and Khaleesi, these pups were far from the magnificent animals that prowled North America before the early Holocene. Instead, as Colossal's own chief science officer later clarified, they were really just grey wolves with around 20 gene edits—not the millions that'd likely be needed to actually create a dire wolf (if such a thing was even possible).
Now, Colossal is at it again. And this time the company wants to bring back all nine species of the giant moa—a flightless bird native to New Zealand that died out as a result of overhunting some 600 years ago. Of course, this announcement differs from the previous one in a key way: They didn't actually bring the bird back (at least, not yet.)
But a media blitz of news coverage, interviews with legendary New Zealand director Peter Jackson, and a flashy announcement video show that Colossal is serious about bringing the giant moa back to the southwestern Pacific island.
This diverse group of birds sported a variety of different attributes and (most notably) sizes. The smallest of the bunch—the bush moa (Anomalopteryx didiformis)—was about the size of a turkey, while the the South Island giant moa (Dinornis robustus) and North Island giant moa (Dinornis novaezealandiae) both stood roughly 11 feet tall.
Even through they looked like a strange cross between an emu and kiwi, the moa's closest living relative is the tinamou group, which lives in central and South America. With the geographical differences providing a big clue, the word 'closest' is doing a lot of heavy lifting, as the two groups separated roughly 60 million years ago.
The Associated Press reports that Colossal will first identify well-preserved moa bones from which DNA can be extracted. For his part, Jackson himself owns the world's largest collection of moa bones (around 300 to 400 specimens). From there, they'll compare the genetic sequences to tinamou and emu, the latter of which will be required for their impressive stature.
'What emus have is very large embryos, very large eggs,' Andrew Pask, a Colossal scientific advisor from the University of Melbourne Australia, told New Scientist. 'And that's one of the things that you definitely need to de-extinct a moa.'
Pask also clarified that this project will be more expansive than the dire wolf project, and that there will be 'orders of magnitude' more DNA edits. The other (sort of) positive is that the moa hasn't been extinct for thousands of years like the dire wolf, so its natural ecosystem hasn't evolved far beyond its extinction.
Some scientists are critical of the idea. Even with the more DNA edits, the resulting 'Colossal moa' won't be a de-extinct moa, but a genetically modified animal that's a close facsimile to the original. It's also unlikely that these GMO-moas will ever be able to roam their natural habitat. They may look like moas, but they won't be able to fulfill the moa's ecological role, which will relegate them to a life as little more than a living museum piece, like the dire wolves.
Despite Colossal's attempts at 'de-extinction,' genetic modification does play an increasingly important role in conservation. Genetic research brought the critically endangered black-footed ferret back from the brink, and that's just one of many examples.
The world is currently experiencing its sixth mass extinction, with potentially thousands of species lost every year. Bringing back woolly mammoths, dire wolves, and giant moa (or close approximations of those ancient creatures) is undeniably enticing, but it doesn't do much for the animals and ecosystems that need our help today.
Get the Issue
Get the Issue
Get the Issue
Get the Issue
Get the Issue
Get the Issue
Get the IssueGet the Issue
Get the Issue
You Might Also Like
The Do's and Don'ts of Using Painter's Tape
The Best Portable BBQ Grills for Cooking Anywhere
Can a Smart Watch Prolong Your Life?
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

These workers don't fear artificial intelligence. They're getting degrees in it.
These workers don't fear artificial intelligence. They're getting degrees in it.

Washington Post

time2 hours ago

  • Washington Post

These workers don't fear artificial intelligence. They're getting degrees in it.

SAN FRANCISCO — Vicky Fowler, who uses ChatGPT for tasks including writing and brainstorming, asked the chatbot out of curiosity to do something more challenging: program a working calculator. To her surprise, it took just seconds. Discovering how fast the artificial intelligence tool could execute a complicated task, Fowler, who has spent two decades working on data protection at a large bank, felt a new urgency to learn more about AI. So she enrolled in the online master's program in AI at the University of Texas at Austin and expects to graduate next year.

Gates Foundation money fills gap in women's health
Gates Foundation money fills gap in women's health

Boston Globe

time2 hours ago

  • Boston Globe

Gates Foundation money fills gap in women's health

McKinsey Advertisement That's why the Gates Foundation's announcement of $2.5 billion in investments through 2030 for women's health — Get The Gavel A weekly SCOTUS explainer newsletter by columnist Kimberly Atkins Stohr. Enter Email Sign Up The investment will fund research and development in maternal and obstetrical care to make pregnancy and childbirth safer, gynecological care and menstrual health, contraception, nutrition, and treatment of sexually transmitted infections. The Gates Foundation has a history of investing in areas that don't draw market-based or government funding. Its goal is to turn basic scientific research into cost-effective products that can be sold worldwide, particularly in lower-income countries. For example, at the STAT event, foundation founder Bill Gates showed off a plastic drape attached to a container with measuring marks that can be placed on the table where a woman is giving birth and used to measure blood loss. Postpartum hemorrhage can kill birthing women, and Gates said the $1 item can help health care providers identify dangerous blood loss, so treatment can be given sooner. Advertisement On the other end of the technological spectrum, Gates highlighted an artificial intelligence-powered ultrasound, currently being tested by Philips, that can send information to a health worker's cellphone about whether a pregnancy is high-risk. The goal is to make it easier for midwives in areas without ultrasound technicians to take an ultrasound, interpret the results, and send women with high-risk pregnancies for more advanced care. The good news for Massachusetts is the state's strong biotech ecosystem means some ideas funded by the Gates Foundation will be researched and developed here. For example, Giovanni Traverso, director of the Laboratory for Translational Engineering at MIT, received money to develop a transdermal patch that could provide women with long-term contraception. The lab is also developing probiotic medications to treat abnormalities in the vaginal microbiome, a condition associated with risks including painful infection and premature birth. Traverso said the foundation invests in high-risk, early-stage research that few commercial investors will back, then focuses on developing cost-effective products. 'The foundation again and again has been willing to take risks recognizing many things we do don't work. But if a few do, they could have a big impact,' Traverso said. Scott Johnson, CEO of Concord-based Comanche Biopharma, is trying to develop the first drug to treat preeclampsia (high blood pressure during pregnancy). If the drug is approved, Johnson said the Gates Foundation will help distribute it in low-income countries. The foundation gave Comanche Biopharma money to improve the chemical manufacturing process and package the drug in a prefilled syringe, making it cheaper and simpler to deliver. Advertisement Johnson hopes after initial trials in wealthier countries, Gates Foundation funding and expertise will help the company do clinical trials in Ghana, Kenya, and South Africa, with an eye toward getting the drug approved and distributed in areas where sales wouldn't otherwise be economically viable. Other Massachusetts grantees include researchers at Beth Israel Lahey Health, Mass General Brigham, Boston Children's Hospital, Harvard University, Fenway Health, Tufts University, and UMass Chan Medical School. Rasa Izadnegahdar, director of maternal, newborn, child nutrition and health for the Gates Foundation, said the goal is to catalyze private-sector investment in an area of health research with global applicability that has never had sustained funding. 'It's a high return-on-investment area,' Izadnegahdar said. 'That could be economic, societal, or from the lens of survival, including in low- and middle-income country settings. When you invest in improving the life of a woman, you're substantially increasing the opportunity of survival for her children, and it has an impact on the community.' Especially as the federal government cuts support for scientific research, Gates's investment highlights the good that can be done by private philanthropy filling the gap. Editorials represent the views of the Boston Globe Editorial Board. Follow us

CNN10 The latest woman to change sports history
CNN10 The latest woman to change sports history

CNN

time10 hours ago

  • CNN

CNN10 The latest woman to change sports history

Today on CNN10: President Trump and Russian President Putin will meet in Alaska to discuss how to end the War in Ukraine. Plus, we celebrate a milestone in sports with MLB's first female umpire, and the return of SpaceX's Dragon Capsule. Then we'll travel to China, where soccer-playing robots show off their footwork, and in Texas, newly uncovered dinosaur tracks give unsuspecting volunteers a peek into prehistoric life. All this and more on today's CNN10!

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store